Cipla USA Inc.

NAICS
325412 Pharmaceutical Preparation ManufacturingThis U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Learn more at the U.S. Census Bureau
Name | Role | Address |
---|---|---|
INCORP SERVICES, INC. | Agent | 222 JEFFERSON BOULEVARD SUITE 200, WARWICK, RI, 02888, USA |
Name | Role | Address |
---|---|---|
BIPLAB MAZUMDAR | TREASURER | 10 INDEPENDENCE BLVD., SUITE 300 WARREN, NJ 07059 USA |
Name | Role | Address |
---|---|---|
BIPLAB MAZUMDAR | SECRETARY | 10 INDEPENDENCE BLVD., SUITE 300 WARREN, NJ 07059 USA |
Name | Role | Address |
---|---|---|
UMANG VOHRA | DIRECTOR | 10 INDEPENDENCE BLVD., SUITE 300 WARREN, NJ 07059 USA |
AS KUMAR | DIRECTOR | 10 INDEPENDENCE BLVD., SUITE 300 WARREN, NJ 07059 USA |
ROBERT STEWART | DIRECTOR | 10 INDEPENDENCE BLVD., SUITE 300 WARREN, NJ 07059 USA |
MARC FALKIN | DIRECTOR | 10 INDEPENDENCE BLVD., SUITE 300 WARREN, NJ 07059 USA |
Name | Role | Address |
---|---|---|
UMANG VOHRA | PRESIDENT | 10 INDEPENDENCE BLVD., SUITE 300 WARREN, NJ 07059 USA |
Name | Role | Address |
---|---|---|
MARC FALKIN | CEO | 10 INDEPENDENCE BLVD., SUITE 300 WARREN, NJ 07059 USA |
Name | Role | Address |
---|---|---|
SHREENIDHEE VARTAK | CFO | 10 INDEPENDENCE BLVD., SUITE 300 WARREN, NJ 07059 USA |
Number | Name | File Date |
---|---|---|
202453667380 | Annual Report | 2024-05-01 |
202330799450 | Annual Report | 2023-03-14 |
202216476370 | Annual Report | 2022-05-01 |
202193109160 | Annual Report | 2021-03-01 |
202035316510 | Annual Report | 2020-02-27 |
This company hasn't received any reviews.
Date of last update: 15 Jul 2025
Sources: Rhode Island Department of State